Please login to the form below

FujiFilm

This page shows the latest FujiFilm news and features for those working in and with pharma, biotech and healthcare.

Pfizer closes on EU approval of lung cancer drug Vizimpro

The two new biosimilars will join products from Amgen, Samsung Bioepis/Biogen, Mylan/Fujifilm Kyowa Kirin, and Novartis’ Sandoz unit in an assault on AbbVie’s market share for the

Latest news

NHS says Humira biosimilar deal will save £300m

s Cyltezo and Mylan’s Hulio, the latter sublicensed from Japan’s Fujifilm Kyowa Kirin.
First Humira biosimilars reach EU market

Copycat versions of the TNF inhibitor from Amgen, Samsung Bioepis/Biogen, Mylan/Fujifilm Kyowa Kirin, and Novartis’ Sandoz unit are starting to become available in their first EU markets now that ... Imraldi. There is no word yet on the roll-out
Fujifilm expands biopharma development and manufacturing business

Company invests 3.2bn yen in US and UK sites. Fujifilm Corporation is investing 3.2bn yen ($28m) to expand the biopharmaceutical manufacturing and development operations of its contract development and ... More specifically, the new investment will
Novartis to buy French radiopharma specialist AAA for $3.9bn

The first patient was recently treated with the drug in Japan, where it is partnered with Fujifilm RI Pharma.
Shire gives up on Momenta-partnered Humira biosimilar

Samsung Bioepis is in pole position in Europe having filed for approval of its SB5 biosimilar in July, while Sandoz, Merck KGaA and FujiFilm/Kyowa Hakko Kirin have candidates in phase

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

Latest Intelligence

Deal Watch March 2016

The sale of the diagnostic imaging business was believed to be hotly contested by Fujifilm and Konica Minolta, with Canon the successful bidder.
Pharma deals in July 2015

Still in Japan, a week later AZ agreed a joint venture with Fujifilm Kyowa Kirin Biologics for the development and commercialisation of a biosimilar version of bevacizumab (Avastin) in phase I ... Fujifilm Kyowa KirinBiologics will transfer the product
Pharma deals in March 2015

The high level of interest in cell therapies generally may have been one reason why Fujifilm acquired Cellular Dynamics for $307m at an eye watering share price premium of 108%. ... Fujifilm expects to achieve significant synergies. Checkpoint inhibitors

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

BIA elects six new board members

The remaining new appointments are Stephen Taylor of Fujifilm Diosynth Biotechnologies; Donna Hackett, director of life sciences consultancy firm KDH BioManagement; and Tim Watts, chief financial officer of Oxford BioMedica.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Medical Writer: Competitive salary and benefits

Home-based Principal Medical Writer – Medical Comms: Salary TBC

Account Director, Medical Education: Salary TBC

PR Associate Director – Consumer Health & Beauty: Salary TBC

Senior Account Manager- Pharma and Life Scienes: Competitive salary and benefits

Freelance Medical Writer - Healthcare Advertising - London: Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day

Senior Medical Writer: Salary TBC

Editorial / Copy Lead – Healthcare Advertising – Central London...: Salary TBC

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Senior Account Director/ Associate Director- Pharma and Life Sci...: Competitive salary and benefits

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Project Manager - Medical Communications – South Wales: Excellent Remuneration Package

Project Manager - Digital Healthcare - London: Excellent Remuneration Package

Editor – Medical Education Agency – Bucks: Salary TBC

Account Manager / Senior Account Manager - Healthcare Advertisin...: Excellent Remuneration

Senior / Principal Medical Writer - MedComms - Home Based / Vari...: Excellent Remuneration Packages

Hybrid Role - Principal Medical Writer / Account Handler - Publi...: Salary TBC

Director – Healthcare PR: Salary TBC

Editorial/ Medical Director – Med Ed & Comms – Home-based...: Salary TBC

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Experienced / Senior Account Director - Publications - London: Up to £80, 000 plus great benefits

Subscribe to our email news alerts

PMHub

Add my company

90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality: How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA: Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad: Six behaviours separate the good brand teams from the bad...